Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Non-Current Assets (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) reported Non-Current Assets of $210.09 million for Q2 2026, up 11.8% from $187.94 million a year earlier and up 71.3% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, Allogene Therapeutics posted Non-Current Assets of $158.16 million, down 35.5% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $245.32 million in FY2024 (+33.5%), $183.72 million in FY2023 (-37.2%), $292.76 million in FY2022 (-49.5%) and $579.51 million in FY2021 (+51.4%).
  • The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q1 2025.
  • Year over year, Non-Current Assets gained in four of the last eight quarters, with an average decline of 5.0%.
  • The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 56.4%); the low point was Q4 2022 (a decline of 49.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $122.67 million (Q1 2026), $158.16 million (Q4 2025) and $179.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn - 210.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 210.09 Mn
Mar 31, 2026 122.67 Mn
Dec 31, 2025 158.16 Mn
Sep 30, 2025 179.05 Mn
Jun 30, 2025 187.94 Mn
Mar 31, 2025 216.41 Mn
Dec 31, 2024 245.32 Mn
Sep 30, 2024 284.71 Mn
Jun 30, 2024 189.76 Mn
Mar 31, 2024 190.99 Mn
Dec 31, 2023 183.72 Mn
Sep 30, 2023 239.96 Mn
Jun 30, 2023 270.91 Mn
Mar 31, 2023 268.66 Mn
Dec 31, 2022 292.76 Mn
Sep 30, 2022 325.42 Mn
Jun 30, 2022 442.59 Mn
Mar 31, 2022 508.35 Mn
Dec 31, 2021 579.51 Mn
Sep 30, 2021 576.39 Mn
API Access

Allogene Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALLO&period=max&api_key=YOUR_API_KEY